Optometrists in South Sioux City, NE Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Tri State Vision Care, Prof Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1601 Cornhusker Dr, South Sioux City, NE 68776 Phone: 402-494-1498 Fax: 402-494-1594 |
Vance Thompson Vision Sioux City, Prof Llc Optometrist Medicare: Medicare Enrolled Practice Location: 201 E 4th St, South Sioux City, NE 68776 Phone: 605-361-3937 |
 Dr. Janet Rose Fett, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 W 29th St, Suite 302, South Sioux City, NE 68776 Phone: 402-494-5533 Fax: 402-494-5534 |
Kelly Jo Sieps, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 201 E 4th St Ste 201, South Sioux City, NE 68776 Phone: 531-625-3941 |
 Dr. Daniel James Kincaid, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 W 29th St Ste 302, South Sioux City, NE 68776 Phone: 402-494-5533 |
Dr. David Michael Kincaid, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 W 29th St, Suite 302, South Sioux City, NE 68776 Phone: 402-494-5533 Fax: 402-494-5534 |
Dr. Laura J Slowey, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1601 Cornhusker Dr, South Sioux City, NE 68776 Phone: 402-494-8858 |
News Archive
Turning stink into therapy for atherosclerosis
In an amusing but amazing turnaround, it seems the most foul-smelling compound on earth, called putrescine, could help relieve chronic inflammation, most importantly in the arterial thickening called atherosclerosis. This discovery is reported in the journal Cell Metabolism in January 2020.
FPB to develop research tools and strategies to include disabled people in future research
While the public has made accommodations for 54.4 million people with disabilities, many researchers regularly exclude people who cannot read, hear or write from participating in their research projects.
Manchester Pharmaceuticals' Chenodal now available for patients suffering from gallstones
Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an important therapy for patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age.
Heart disease risk factors in childhood predicts likelihood of atherosclerosis as adults
Measuring heart disease risk factors in children at or after age 9 helped predict the likelihood of atherosclerosis in adulthood, according to a study in Circulation: Journal of the American Heart Association.
› Verified 6 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists
Optometrists
Occupational Therapists